Ironwood Pharmaceuticals' Blowout Q2 Results: What You'll Want to Know
Ironwood Pharmaceuticals (NASDAQ: IRWD) shareholders couldn't have been happy campers when the drugmaker reported its quarterly results in May. The company announced that revenue dropped by 0.6% from the prior-year period while its bottom line deteriorated significantly.
Any questions investors had about Ironwood's second quarter were answered when the company announced its Q2 results after the market closed on Tuesday. Here's what you need to know from Ironwood's quarterly update.
Image source: Getty Images.
Quelle Fool.com
